Parametersa Control (n=8) Mean ± SD rhGH 0.1 mg/kg (n=6) Mean ± SD rhGH 2 mg/kg (n=8)
Mean ± SD
T1/2 (hr) 1.86 ± 0.32 1.30 ± 0.22b 1.72 ± 0.10c
MRT (hr) 2.03 ± 0.33 1.70 ± 0.43 1.97 ± 0.26
AUCt (µg*hr/mL) 35.1 ± 4.6 38.2 ± 6.9 49.5 ± 8.2bc
AUC¥ (µg*hr/mL) 37.3 ± 5.5 39.3 ± 6.8 51.4 ± 8.4bc
Varea (L/kg) 1.80 ± 0.17 1.21 ± 0.21b 1.23 ± 0.22b
Vss (L/kg) 1.37 ± 0.19 1.10 ± 0.29 0.990 ± 0.249b
CL (L/hr/kg) 0.685 ± 0.109 0.654 ± 0.119 0.497 ± 0.076bc
CLr (L/hr/kg) 0.0175 ± 0.0037 0.0136 ± 0.0050 0.0135 ± 0.0091b
CLm (L/hr/kg) 0.667 ± 0.105 0.643 ± 0.171 0.484 ± 0.075b
fe 0.0254 ± 0.0026 0.0206 ± 0.0048 0.0274 ± 0.0040
a T1/2 = half-life; MRT = mean residence time; AUCt = area under the plasma curve to the last concentration; AUC¥ = area under the plasma curve to the infinity; Varea = apparent volume of distribution; Vss = apparent volume of distribution at steady state; CL = total body clearance; CLr = renal clearance; CLm = metabolic clearance; fe = fraction excreted unchanged
b Significantly different from control group, p<0.05
c Significantly different from the rhGH 0.1 mg/kg/day group, p<0.05
Table 2: Comparison of carbamazepine (25 mg/kg IV) pharmacokinetics in male rats receiving rhGH for 5 days.
Goto home»